-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate total amount of expenses directly related to the marketing or selling of products or services.
-
Summary
-
Coeptis Therapeutics Inc. quarterly/annual Selling and Marketing Expense history and growth rate from Q1 2020 to Q3 2022.
- Coeptis Therapeutics Inc. Selling and Marketing Expense for the quarter ending September 30, 2022 was $2.86K.
- Coeptis Therapeutics Inc. Selling and Marketing Expense for the twelve months ending September 30, 2022 was $6.91K, a 27.5% decline year-over-year.
- Coeptis Therapeutics Inc. annual Selling and Marketing Expense for 2021 was $2.92K, a 55.8% decline from 2020.
Selling and Marketing Expense, Trailing 12 Months (USD)
Selling and Marketing Expense, Quarterly (USD)
Selling and Marketing Expense, YoY Quarterly Growth (%)